<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02450214</url>
  </required_header>
  <id_info>
    <org_study_id>OAIC N 722/15</org_study_id>
    <nct_id>NCT02450214</nct_id>
  </id_info>
  <brief_title>Intraoperative Ketamine and Magnesium Therapy for Control of Postoperative Pain After a Liposuction and Lipoabdominoplasty</brief_title>
  <acronym>KEMPLA</acronym>
  <official_title>Efficacy of Ketamine and Magnesium Association in the Postoperative Pain After Liposuction and Lipoabdominoplasty: Prospective, Randomized and Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chile</source>
  <brief_summary>
    <textblock>
      Lipoabdominoplasty and liposuction are one of the most common plastic surgeries. The
      management of postoperative pain is complex. Non Steroidal Anti Inflammatory Drugs (NSAIDs)
      are insufficient, while opioids are avoided by their adverse effects and regional techniques
      are hampered by a premature discharge. In this context, the investigators seek an
      intraoperative multimodal analgesic technique blocking NMDA receptors with ketamine plus
      magnesium to significantly decrease postoperative pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioids consumption</measure>
    <time_frame>12 h after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Pain (Postoperative Pain and Disability Scale)</measure>
    <time_frame>2, 7, 14, 21, 45 and 90 days after surgery</time_frame>
    <description>Postoperative Pain and Disability Scale (Body-PPDS) will be used to quantify pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early postoperative pain (Visual analogue pain scale)</measure>
    <time_frame>0, 2, 4, 6, 12 and 24 h after surgery</time_frame>
    <description>Visual analogue pain scale (0-10) will be used to quantify pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early postoperative pain (Time to first request for supplemental analgesia)</measure>
    <time_frame>1 day</time_frame>
    <description>Time to first request for supplemental analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability (Time delay in returning to work)</measure>
    <time_frame>90 days</time_frame>
    <description>Time delay in returning to work.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Chronic Pain (McGill scale)</measure>
    <time_frame>Day after surgery, 7, 30 and 90 days after surgery</time_frame>
    <description>McGill scale for chronic painwill be used to quantify pain</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Drug Side Effect</measure>
    <time_frame>First day after surgery</time_frame>
    <description>Hallucinations, unpleasent dreams or some patient discomfort, sedation level, pruritus, hypotension, bradycardia, urinary retention, nausea, vomiting.</description>
  </other_outcome>
  <other_outcome>
    <measure>Other Variables</measure>
    <time_frame>First day</time_frame>
    <description>Sociodemographic variables; surgical variables as liters of aspirated fat, weight of resected flap, operative time, bleeding measured as the difference between pre and postoperative hemoblobinemia, immediate postoperative complications such as bleeding or hematoma and thromboembolic complications; anesthetic variables as total amount of remifentanil and sevorane consumption.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Control group (C)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>50 mL syringe with saline, plus 1 flask of 100 mL saline (Saline)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine group (K)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 mL syringe with ketamine (50mg / 50ml), plus 1 flask of 100 mL saline (Ketamine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Magnesium + ketamine group (MGK)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50mL syringe with ketamine (50mg / 50ml), plus a flask of 100ml of saline with 5 g of magnesium sulfate (Ketamine + magnesium)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>50 mL syringe will be infused at 0.3 mL/Kg in bolus and then 0.15 mL/Kg/h 100 mL flask will be infused at 1mL/Kg in bolus for 30 min and then 0.25mL/Kg/h</description>
    <arm_group_label>Control group (C)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>50 mL syringe will be infused at 0.3 mL/Kg in bolus and then 0.15 mL/Kg/h 100 mL flask will be infused at 1mL/Kg in bolus for 30 min and then 0.25mL/Kg/h</description>
    <arm_group_label>Ketamine group (K)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine + magnesium</intervention_name>
    <description>50 mL syringe will be infused at 0.3 mL/Kg in bolus and then 0.15 mL/Kg/h 100 mL flask will be infused at 1mL/Kg in bolus for 30 min and then 0.25mL/Kg/h</description>
    <arm_group_label>Magnesium + ketamine group (MGK)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female and male

          -  18 years or older

          -  Liposuction and lipoabdominoplasty

          -  ASA 1 and 2

          -  BMI 21-28 Kg/m2

          -  Full secondary education

        Exclusion Criteria:

          -  Patients with surgeries added to the main proceedings

          -  Scheduled to tuck in Flor de Lis or Body Lift

          -  History of use of analgesic drugs 48 hours before surgery

          -  Peripheral central neurological diseases

          -  Known allergy will be excluded to medication in use in this study (ketamine,
             magnesium, clindamycin and penicillin or other)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Clinico de la Universidad de Chile</name>
      <address>
        <city>Santiago</city>
        <state>RM</state>
        <zip>7690306</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2015</study_first_submitted>
  <study_first_submitted_qc>May 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2015</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Chile</investigator_affiliation>
    <investigator_full_name>Veronica Varas Vega</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Ketamine</keyword>
  <keyword>Magnesium</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Liposuction</keyword>
  <keyword>Lipoabdominoplasty</keyword>
  <keyword>Preemptive analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

